Kouji H Harada Selected Research

Brachydactyly type A1

1/2021

Deletion of 2 amino acids in IHH in a Japanese family with brachydactyly type A1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kouji H Harada Research Topics

Disease

4	Pain (Aches) 06/2021 - 01/2016
3	Body Weight (Weight, Body) 04/2020 - 04/2008
3	Neoplasms (Cancer) 09/2013 - 01/2013
2	Chronic Renal Insufficiency 10/2020 - 01/2016
2	Moyamoya Disease (Moya-Moya Disease) 01/2020 - 06/2015
2	Chronic Kidney Diseases of Uncertain Etiology 07/2019 - 07/2011
2	Atrial Fibrillation 06/2019 - 04/2017
2	Stroke (Strokes) 06/2019 - 04/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2013 - 01/2013
1	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Brachydactyly type A1 01/2021
1	Fatigue 01/2021
1	Hyperalgesia 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2020
1	Hypoxia (Hypoxemia) 07/2018
1	Insulinoma 01/2018
1	Diabetes Mellitus 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2016
1	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2015
1	Waterborne Diseases 01/2015
1	Hypertension (High Blood Pressure) 01/2014
1	Proteinuria 01/2014
1	Venous Thromboembolism 08/2013
1	Insulin Resistance 03/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Wounds and Injuries (Trauma) 01/2010
1	Cleft Palate (Palate, Cleft) 02/2009
1	Hyperinsulinism (Hyperinsulinemia) 06/2008

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 12/2021 - 09/2013
2	Voltage-Gated Sodium ChannelsIBA 06/2021 - 01/2016
2	Drinking WaterIBA 10/2020 - 01/2015
2	AnticoagulantsIBA 06/2019 - 04/2017
2	CreatinineIBA 01/2014 - 07/2011
2	LeptinIBA 03/2013 - 06/2008
2	Cadherins (E-Cadherin)IBA 01/2013 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 01/2013
2	PPAR alphaIBA 01/2010 - 04/2008
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2022
1	ORALIT (ORS)IBA 12/2021
1	perfluorotridecanoic acidIBA 12/2021
1	SodiumIBA 06/2021
1	Glutamic Acid (Glutamate)FDA Link 06/2021
1	Glutamine (L-Glutamine)FDA Link 06/2021
1	gosha-jinki-ganIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Amino Acids FDA Link 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	FluoridesIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 04/2020
1	UbiquitinIBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	Trace Elements (Biometals)IBA 07/2019
1	Warfarin (Coumadin)FDA LinkGeneric 06/2019
1	RivaroxabanIBA 06/2019
1	Dabigatran FDA Link 06/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2019
1	Caveolin 1IBA 07/2018
1	Adiponectin ReceptorsIBA 01/2018
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	AdiponectinIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2016
1	NeonicotinoidsIBA 01/2016
1	laminin beta2 (S-laminin)IBA 09/2015
1	ATPases Associated with Diverse Cellular ActivitiesIBA 06/2015
1	ChlorineIBA 01/2015
1	Disinfectants (Biocides)IBA 01/2015
1	Protein SIBA 08/2013
1	Blood Glucose (Blood Sugar)IBA 03/2013
1	Insulin (Novolin)FDA Link 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 03/2013
1	Cyclin D1IBA 01/2013
1	MycotoxinsIBA 07/2011
1	AflatoxinsIBA 07/2011
1	OchratoxinsIBA 07/2011
1	Ammonium CompoundsIBA 01/2010
1	SaltsIBA 01/2010
1	perfluorooctaneIBA 02/2009
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 06/2008

Therapy/Procedure

2	Therapeutics 06/2019 - 04/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Nuclear Power Plants 05/2020